Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation
出版年份 2016 全文链接
标题
Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation
作者
关键词
-
出版物
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 14, Issue 11, Pages 2124-2131
出版商
Wiley
发表日期
2016-09-19
DOI
10.1111/jth.13427
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
- (2016) Jan Beyer-Westendorf et al. EUROPACE
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
- (2016) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation
- (2016) J. Hecker et al. THROMBOSIS AND HAEMOSTASIS
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation
- (2015) Giacomo Zoppellaro et al. Expert Opinion On Drug Safety
- Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013
- (2015) Carlos Martinez et al. HEART
- To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort
- (2015) Serena Granziera et al. Internal and Emergency Medicine
- Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
- (2015) Laila Staerk et al. BMJ-British Medical Journal
- Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
- (2015) Laila Staerk et al. BMJ-British Medical Journal
- Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
- (2014) Emily C. O’Brien et al. AMERICAN HEART JOURNAL
- The European Stroke Organisation (ESO) Guidelines
- (2014) T. Steiner et al. International Journal of Stroke
- Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation
- (2013) Winnie W. Nelson et al. AMERICAN JOURNAL OF CARDIOLOGY
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
- (2013) Giuseppe Mancia et al. BLOOD PRESSURE
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- Persistence of Warfarin Therapy for Residents in Long-term Care Who Have Atrial Fibrillation
- (2013) Aarti A. Patel et al. CLINICAL THERAPEUTICS
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Significant Underuse of Warfarin in Patients with Nonvalvular Atrial Fibrillation: Results from the China National Stroke Registry
- (2013) Chunjuan Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2013) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation
- (2012) Tara Gomes et al. ARCHIVES OF INTERNAL MEDICINE
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients
- (2012) T. Wilke et al. EUROPACE
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Bleeding risk assessment and management in atrial fibrillation patients
- (2011) Laurent Fauchier et al. THROMBOSIS AND HAEMOSTASIS
- Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.
- (2011) Luciano Crippa et al. THROMBOSIS AND HAEMOSTASIS
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
- (2010) Isla M. Ogilvie et al. AMERICAN JOURNAL OF MEDICINE
- Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
- (2010) Margaret C. Fang et al.
- Age as a Risk Factor for Stroke in Atrial Fibrillation Patients
- (2010) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stroke in the Very Elderly: Hospital Care, Case Fatality and Disposition
- (2009) Gustavo Saposnik et al. CEREBROVASCULAR DISEASES
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation
- (2008) R. Nieuwlaat et al. EUROPEAN HEART JOURNAL
- Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
- (2008) A. M. GALLAGHER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More